Early treatment with Drotrecogin alfa (activated) was associated with reduced hospital resource use in adult severe sepsis patients with an APACHE II score of 25 or greater at baseline: results from ENHANCE

Lignende værker

• Eligibility for drotrecogin alfa therapy on the basis of APACHE II score and organ failure
  af: Shulman, R, et al.
  Udgivet: (2005)
• The efficacy of Drotrecogin alfa (activated) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
  af: Vincent, J, et al.
  Udgivet: (2004)
• Severe sepsis and drotrecogin alfa (activated) use: results from the PROGRESS registry
  af: Beale, R, et al.
  Udgivet: (2007)
• Early treatment with Drotrecogin alfa (activated) was associated with reduced hospital resource use in adult severe sepsis patients with two or more organ dysfunctions at baseline: results from ENHANCE
  af: Vincent, J, et al.
  Udgivet: (2004)
• Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis
  af: Bernard, Gordon R, et al.
  Udgivet: (2003)